<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT933-6830</title>
	</head>
	<body>
		<main>
			<p>930825 FT  25 AUG 93 / International Company News: Novo Nordisk to invest Dollars 8m in US researcher NOVO Nordisk is making an Dollars 8m equity investment in Anergen, a Californian pharmaceuticals research company. The deal gives the Danish company 17.5 per cent of Anergen. The agreement between Novo Nordisk, a leading force in insulin production and diabetes care, will give the Danish group marketing rights (outside North America) to products developed by Anergen, which specialises in developing therapies for a group of diseases including diabetes and multiple sclerosis. In addition to the investment, Novo Nordisk will fund research and development programmes, bringing its total investment in Anergen to around Dollars 25m, said Novo Nordisk.</p>
		</main>
</body></html>
            